While many school districts had begun serving students—especially elementary school children—in person this fall, another surge in COVID-19 numbers across the country has led to many schools moving back to virtual learning. Large…

While advanced age and comorbidities are well-known risk factors for severe illness caused by COVID-19, it was still not understood why some people became gravely ill, whereas other patients of similar backgrounds recovered quickly.…

Candida albicans infections in the mouth are often painful for people who develop infections such as burning mouth syndrome or thrush.

United States pharmaceutical giant, Pfizer, whose two-shot COVID-19 vaccine recently showed 90% effectiveness in preliminary studies, is ready to roll out millions of doses as soon as it receives approval from the US Food and Drug…

A new study found that patients who recovered from COVID-19 were at elevated risk for mental illness. Published in the British medical journal The Lancet, results demonstrated that one in five patients who had recovered from a SARS-CoV-2…

On November 9, the United States Food and Drug Administration issued an emergency use authorization (EUA) to bamlanivimab for the treatment of mild-to-moderate COVID-19. The monoclonal antibody therapy is authorized for COVID-19 patients…

The American pharmaceutical company Pfizer reported that its COVID-19 vaccine is highly effective in preventing infection with the novel coronavirus in preliminary studies. In light of rising case numbers across the United States, this is…

Sunstar Americas, Inc. (SAI) is voluntarily recalling Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 6/30/22 – 9/30/22 (see specific lots below) to the consumer level.  This product may be…

A mutated version of the coronavirus has infected the farmed mink population in Denmark, the largest supplier of mink fur in the world. Thus far, the mutation has impacted more than 200 mink farms and over 200 Danes have been infected with…

Columbia University researchers have developed a nasal spray designed to prevent infection with the novel coronavirus, and an initial study conducted on ferrets demonstrates efficacy. While the study was small and has not undergone peer…